KR20050011139A - 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 - Google Patents
프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 Download PDFInfo
- Publication number
- KR20050011139A KR20050011139A KR1020030050112A KR20030050112A KR20050011139A KR 20050011139 A KR20050011139 A KR 20050011139A KR 1020030050112 A KR1020030050112 A KR 1020030050112A KR 20030050112 A KR20030050112 A KR 20030050112A KR 20050011139 A KR20050011139 A KR 20050011139A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- propylbenzylic
- acid ester
- hydrochloride
- benzylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
화합물 번호 | 방광수축억제작용 | 타액분비억제작용 | 타액분비억제작용방광수축억제작용 | 선택성 |
3 | 9.4 | 33.9 | 3.6 | 4.0 |
4 | 9.8 | 56.6 | 5.8 | 6.2 |
12 | 10.0 | 22.5 | 2.3 | 2.4 |
염산 옥시부티닌 | 3.4 | 3.5 | 1.0 | 1.1 |
염산 프로피페린 | 9.9 | 9.2 | 0.9 | 1.0 |
Claims (5)
- O-n-프로필벤질릭산 에스터를 4-히드록시-1-메칠피페리딘과 반응시켜 프로피베린를 제조한 다음 염산가스로 결정화하여 염산프로피베린을 제조하는 것을 특징으로 하는 염산프로피베린의 제조방법.
- 제 1항에 있어서, 질소분위기 하에서 21% 소디움에톡사이드를 가하고, O-n-프로필벤질릭산 에스터, 톨루엔, 벤젠 및 4-히드록시-1-메칠피페리딘을 차례로 가한 후 반응시켜 프로피베린를 제조한 다음 염산가스로 결정화하여 염산프로피베린을 제조하는 것을 특징으로 하는 염산프로피베린의 제조방법.
- 제 1항에 있어서, 상기 O-n-프로필벤질릭산 에스터는 벤질릭산에 메탄올, 에탄올, n-프로판올 및 이소프로판올로 이루어진 그룹 중에서 선택되는 하나 이상의 알콜과 반응시켜 벤질릭산에스터를 제조하는 단계; 및 질소분위기 하에서 테트라히드로퓨란, 트리페닐포스핀 및 1-프로판올을 차례로 넣고 교반 후 상기 반응액에 40% 디에칠아조디카르복실레이트를 첨가한 후 벤질릭산에스터를 테트라히드로퓨란에 녹인 액을 첨가하여 반응시켜 O-n-프로필벤질릭산 에스터를 제조하는 단계로 이루어진 것을 특징으로 하는 염산프로피베린의 제조방법.
- 제 1항에 있어서, 상기 O-n-프로필벤질릭산 에스터는 벤질릭산에 오염화인을넣고 반응시킨 후 1-프로판올을 반응시켜 O-n-프로필벤질릭산을 제조하는 단계; 및 상기 O-n-프로필벤질릭산을 메탄올, 에탄올, n-프로판올 및 이소프로판올로 이루어진 그룹 중에서 선택되는 하나 이상의 알콜과 반응시켜 O-n-프로필벤질릭산 에스터를 제조하는 단계로 이루어진 것을 특징으로 하는 염산프로피베린의 제조방법.
- 제 1항에 있어서, 상기 O-n-프로필벤질릭산 에스터는 벤질릭산, 디옥산 및 무수탄산칼륨을 차례로 첨가하여 교반 후 상기 반응물에 프로필클로라이드를 반응시켜 O-n-프로필벤질릭산을 제조하는 단계; 및 상기 O-n-프로필벤질릭산을 메탄올, 에탄올, n-프로판올 및 이소프로판올로 이루어진 그룹 중에서 선택되는 하나 이상의 알콜과 반응시켜 O-n-프로필벤질릭산 에스터를 제조하는 단계로 이루어진 것을 특징으로 하는 염산프로피베린의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0050112A KR100510788B1 (ko) | 2003-07-22 | 2003-07-22 | 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0050112A KR100510788B1 (ko) | 2003-07-22 | 2003-07-22 | 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050011139A true KR20050011139A (ko) | 2005-01-29 |
KR100510788B1 KR100510788B1 (ko) | 2005-08-26 |
Family
ID=37223239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-0050112A KR100510788B1 (ko) | 2003-07-22 | 2003-07-22 | 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100510788B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011114195A1 (en) | 2010-03-15 | 2011-09-22 | Ramesha Andagar Ramakrishna | Synthesis of propiverine hydrochloride |
WO2014025569A1 (en) | 2012-08-09 | 2014-02-13 | Chase Pharmaceuticals Corporation | Piperidinium quaternary salts |
CN103613502A (zh) * | 2013-10-12 | 2014-03-05 | 武汉怡兴化工有限公司 | 1,1-二苯基-1-羟基乙酸乙酯制备方法 |
EP4035668A1 (en) | 2012-09-05 | 2022-08-03 | Chase Pharmaceuticals Corporation | Anticholinergic neuroprotective composition and methods |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102218063B (zh) * | 2011-04-12 | 2013-03-13 | 贵州神奇制药有限公司 | 盐酸丙哌维林药物的制备方法和产品及其检测方法 |
-
2003
- 2003-07-22 KR KR10-2003-0050112A patent/KR100510788B1/ko active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011114195A1 (en) | 2010-03-15 | 2011-09-22 | Ramesha Andagar Ramakrishna | Synthesis of propiverine hydrochloride |
EP2470504A1 (en) * | 2010-03-15 | 2012-07-04 | Ramesha Andagar Ramakrishna | Synthesis of propiverine hydrochloride |
EP2470504A4 (en) * | 2010-03-15 | 2012-07-25 | Ramakrishna Ramesha Andagar | SYNTHESIS OF PROPRIERINE HYDROCHLORIDE |
JP2012530050A (ja) * | 2010-03-15 | 2012-11-29 | ラマクリシュナ、ラメシャ アンダガル | 塩酸プロピベリンの合成 |
WO2014025569A1 (en) | 2012-08-09 | 2014-02-13 | Chase Pharmaceuticals Corporation | Piperidinium quaternary salts |
EP4035668A1 (en) | 2012-09-05 | 2022-08-03 | Chase Pharmaceuticals Corporation | Anticholinergic neuroprotective composition and methods |
CN103613502A (zh) * | 2013-10-12 | 2014-03-05 | 武汉怡兴化工有限公司 | 1,1-二苯基-1-羟基乙酸乙酯制备方法 |
CN103613502B (zh) * | 2013-10-12 | 2016-01-06 | 武汉怡兴化工有限公司 | 1,1-二苯基-1-羟基乙酸乙酯制备方法 |
Also Published As
Publication number | Publication date |
---|---|
KR100510788B1 (ko) | 2005-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100406011C (zh) | 含乙酸酰基苯胺衍生物作为活性成分的膀胱活动过度的治疗药物 | |
US20090105298A1 (en) | Pharmaceutical composition for therapy of interstitial cystitis | |
KR20180008918A (ko) | 과민성 방광 치료를 위한 베타-3 아드레날린 수용체 작용제 및 무스카린 수용체 길항제의 약학적 배합제 | |
JP2021505547A (ja) | 疼痛を治療するための薬物の製造におけるmorアゴニストと組み合わせたkorアゴニストの使用 | |
MXPA04010934A (es) | Composiciones y metodos para combatir disfunciones del tracto urinario inferior con agonistas del receptor delta-opioide. | |
AU777517B2 (en) | Dermal anesthetic agents | |
KR100510788B1 (ko) | 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 | |
KR100500760B1 (ko) | 염산 프로피베린의 제조방법 | |
US20060276531A1 (en) | Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia | |
US5712277A (en) | Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for the treatment of pain and oedema | |
JP5908072B2 (ja) | 腹圧性尿失禁予防剤及び/又は治療剤 | |
US7354949B2 (en) | Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia | |
JP4284065B2 (ja) | 置換された6−ジメチルアミノメチル−1−フェニル−シクロヘキサン化合物を尿失禁の治療に使用する方法 | |
ES2292636T3 (es) | 1-(2-m-metanosulfanomidofeniletil)-4-(m-trifluorometilfenil)piper. | |
CN104093707B (zh) | 乙酸酯化合物或其盐 | |
JPS6239567A (ja) | ベンジル酸−4−ピペリジルエステル誘導体 | |
CA2647329A1 (en) | Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine | |
JP3713271B6 (ja) | 3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンの浮腫および痛みの治療のための使用 | |
WO2006112565A1 (en) | Therapeutic drugs for pollakiuria and urinary incontinence containing optical active propiophenon and its salts | |
US20070254899A1 (en) | Soluble salts of thieno[2,3-d]pyrimidine derivatives | |
CN105283444A (zh) | 新颖的氟代二苯乙醇酸酯化合物及其盐 | |
WO1996031479A1 (en) | Novel heterocyclic compounds | |
AU2002338234A1 (en) | Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120711 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130620 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140818 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150818 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160816 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170818 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190807 Year of fee payment: 15 |